agilon health, inc. - Common stock, $0.01 par value (AGL)

CUSIP: 00857U107

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-461,593
Put/Call ratio
118%
SEC-reported price per share
$2.30
Number of holders
204
Value change
-$2,996,581
Number of buys
116
Open additional details 1 more signal available
Number of sells
74
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,608,126

Security key

00857U107

Report period

Q2 2025

Institutions

204

Top holders

10

Ownership snapshot

Top reported holders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
CD&R Investment Associate...
Comparable rows
3/15
Latest evidence
31 Mar 2025
13F 13D/G 3/4/5 Lead comparable stake: 12% 12 rows are not safely comparable across share classes. 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 12%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 3
MORGAN STANLEY 12%
WELLINGTON MANAGEMENT GROUP LLP 3.6%
Capital International Investors 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13F 13D/G
Company
12%
Reported 13D/G · 31 Mar 2025
$225,305,933
52,033,701 shares
— 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
3.6%
Reported 13D/G · 31 Mar 2025
$64,893,264
14,986,897 shares
— 31 Mar 2025
Capital International Investors
13F 13D/G
Company
2.4%
Reported 13D/G · 30 Jun 2025
$96,697,010
22,331,873 shares
— 31 Mar 2025
CD&R Investment Associates IX, Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$1,122,000,000
100,000,000 shares
— 18 May 2023
Clayton, Dubilier & Rice, LLC
13F
Company
13F
—
denominator unverified
$433,000,000
100,000,000 shares
— 31 Mar 2025
Capital World Investors
13F
Company
13F
—
denominator unverified
$231,252,029
53,406,935 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
204
Shares
399,328,682
Rows available
204
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
198
Q2 2025 holders
204
Holder diff
6
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .